PSP-0119
PSP-0119 is a highly efficient and effective PROTAC degrader targeting IRAK4 (IC50 = 2.83 nM) . PSP-0119 can inhibit IRAK4 kinase activity, NF-κβ activity, and IL-1β-induced IRAK4 phosphorylation. PSP-0119 degrades IRAK4 in FLT3-mutant AML cell lines, sparing FLT3-wild-type AML cells, FLT3-wild-type samples, and normal bone marrow. PSP-0119 downregulates alpha-enolase (eNOS) of MOLM-13 cells. PSP-0119 can be used for the study of Acute Myeloid Leukemia (AML) [1].
Product Specifications
UNSPSC
12352005
Target
Enolase; IRAK; NF-κB; PROTACs
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; PROTAC
Field of Research
Cancer; Inflammation/Immunology
Smiles
COC1=CC(N2CCN(CC2)C(CCCC(NC3=CC=CC4=C3CN(C4=O)C5CCC(NC5=O)=O)=O)=O)=CC=C1NC(C6=CC=CC(C7=NNC=C7)=N6)=O
Molecular Formula
C38H39N9O7
Molecular Weight
733.77
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IRAK4; NF-κB
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ganglioside GM1 hIgM Human Monoclonal Antibody
F13A1 (Coagulation Factor XIII A Chain, Coagulation Factor XIIIa, Protein-glutamine gamma-glutamyltransferase A Chain, Transglutaminase A Chain, F13A) (FITC)